Enantioselectivity in Drug Pharmacokinetics and Toxicity: Pharmacological Relevance and Analytical Methods
Enzymes, receptors, and other binding molecules in biological processes can recognize enantiomers as different molecular entities, due to their different dissociation constants, leading to diverse responses in biological processes. Enantioselectivity can be observed in drugs pharmacodynamics and in...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/11/3113 |
id |
doaj-fcf0069d51c7499fbf204e429c6cd794 |
---|---|
record_format |
Article |
spelling |
doaj-fcf0069d51c7499fbf204e429c6cd7942021-06-01T00:51:12ZengMDPI AGMolecules1420-30492021-05-01263113311310.3390/molecules26113113Enantioselectivity in Drug Pharmacokinetics and Toxicity: Pharmacological Relevance and Analytical MethodsMaria Miguel Coelho0Carla Fernandes1Fernando Remião2Maria Elizabeth Tiritan3Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia da Universidade do Porto, Rua Jorge de Viterbo Ferreira, 228, 4050-313 Porto, PortugalLaboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia da Universidade do Porto, Rua Jorge de Viterbo Ferreira, 228, 4050-313 Porto, PortugalUnidade de Ciências Biomoleculares Aplicadas (UCIBIO)-REQUIMTE, Laboratório de Toxicologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, PortugalLaboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia da Universidade do Porto, Rua Jorge de Viterbo Ferreira, 228, 4050-313 Porto, PortugalEnzymes, receptors, and other binding molecules in biological processes can recognize enantiomers as different molecular entities, due to their different dissociation constants, leading to diverse responses in biological processes. Enantioselectivity can be observed in drugs pharmacodynamics and in pharmacokinetic (absorption, distribution, metabolism, and excretion), especially in metabolic profile and in toxicity mechanisms. The stereoisomers of a drug can undergo to different metabolic pathways due to different enzyme systems, resulting in different types and/or number of metabolites. The configuration of enantiomers can cause unexpected effects, related to changes as unidirectional or bidirectional inversion that can occur during pharmacokinetic processes. The choice of models for pharmacokinetic studies as well as the subsequent data interpretation must also be aware of genetic factors (such as polymorphic metabolic enzymes), sex, patient age, hepatic diseases, and drug interactions. Therefore, the pharmacokinetics and toxicity of a racemate or an enantiomerically pure drug are not equal and need to be studied. Enantioselective analytical methods are crucial to monitor pharmacokinetic events and for acquisition of accurate data to better understand the role of the stereochemistry in pharmacokinetics and toxicity. The complexity of merging the best enantioseparation conditions with the selected sample matrix and the intended goal of the analysis is a challenge task. The data gathered in this review intend to reinforce the importance of the enantioselectivity in pharmacokinetic processes and reunite innovative enantioselective analytical methods applied in pharmacokinetic studies. An assorted variety of methods are herein briefly discussed.https://www.mdpi.com/1420-3049/26/11/3113chiralitymetabolismenantiomerschiral analyseschiral stationary phases |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Maria Miguel Coelho Carla Fernandes Fernando Remião Maria Elizabeth Tiritan |
spellingShingle |
Maria Miguel Coelho Carla Fernandes Fernando Remião Maria Elizabeth Tiritan Enantioselectivity in Drug Pharmacokinetics and Toxicity: Pharmacological Relevance and Analytical Methods Molecules chirality metabolism enantiomers chiral analyses chiral stationary phases |
author_facet |
Maria Miguel Coelho Carla Fernandes Fernando Remião Maria Elizabeth Tiritan |
author_sort |
Maria Miguel Coelho |
title |
Enantioselectivity in Drug Pharmacokinetics and Toxicity: Pharmacological Relevance and Analytical Methods |
title_short |
Enantioselectivity in Drug Pharmacokinetics and Toxicity: Pharmacological Relevance and Analytical Methods |
title_full |
Enantioselectivity in Drug Pharmacokinetics and Toxicity: Pharmacological Relevance and Analytical Methods |
title_fullStr |
Enantioselectivity in Drug Pharmacokinetics and Toxicity: Pharmacological Relevance and Analytical Methods |
title_full_unstemmed |
Enantioselectivity in Drug Pharmacokinetics and Toxicity: Pharmacological Relevance and Analytical Methods |
title_sort |
enantioselectivity in drug pharmacokinetics and toxicity: pharmacological relevance and analytical methods |
publisher |
MDPI AG |
series |
Molecules |
issn |
1420-3049 |
publishDate |
2021-05-01 |
description |
Enzymes, receptors, and other binding molecules in biological processes can recognize enantiomers as different molecular entities, due to their different dissociation constants, leading to diverse responses in biological processes. Enantioselectivity can be observed in drugs pharmacodynamics and in pharmacokinetic (absorption, distribution, metabolism, and excretion), especially in metabolic profile and in toxicity mechanisms. The stereoisomers of a drug can undergo to different metabolic pathways due to different enzyme systems, resulting in different types and/or number of metabolites. The configuration of enantiomers can cause unexpected effects, related to changes as unidirectional or bidirectional inversion that can occur during pharmacokinetic processes. The choice of models for pharmacokinetic studies as well as the subsequent data interpretation must also be aware of genetic factors (such as polymorphic metabolic enzymes), sex, patient age, hepatic diseases, and drug interactions. Therefore, the pharmacokinetics and toxicity of a racemate or an enantiomerically pure drug are not equal and need to be studied. Enantioselective analytical methods are crucial to monitor pharmacokinetic events and for acquisition of accurate data to better understand the role of the stereochemistry in pharmacokinetics and toxicity. The complexity of merging the best enantioseparation conditions with the selected sample matrix and the intended goal of the analysis is a challenge task. The data gathered in this review intend to reinforce the importance of the enantioselectivity in pharmacokinetic processes and reunite innovative enantioselective analytical methods applied in pharmacokinetic studies. An assorted variety of methods are herein briefly discussed. |
topic |
chirality metabolism enantiomers chiral analyses chiral stationary phases |
url |
https://www.mdpi.com/1420-3049/26/11/3113 |
work_keys_str_mv |
AT mariamiguelcoelho enantioselectivityindrugpharmacokineticsandtoxicitypharmacologicalrelevanceandanalyticalmethods AT carlafernandes enantioselectivityindrugpharmacokineticsandtoxicitypharmacologicalrelevanceandanalyticalmethods AT fernandoremiao enantioselectivityindrugpharmacokineticsandtoxicitypharmacologicalrelevanceandanalyticalmethods AT mariaelizabethtiritan enantioselectivityindrugpharmacokineticsandtoxicitypharmacologicalrelevanceandanalyticalmethods |
_version_ |
1721413818550059008 |